Leukemia Research
Volume 28, Issue 8 , Pages 845-850, August 2004

Treatment of human chronic lymphocytic leukemia cells with the proteasome inhibitor bortezomib promotes apoptosis

  • Todd W Kelley

      Affiliations

    • Department of Clinical Pathology, L11, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, USA
    • ,
  • Serhan Alkan

      Affiliations

    • Department of Pathology, Loyola University Medical Center, Maywood, IL, USA
    • ,
  • Gordan Srkalovic

      Affiliations

    • Department of Hematology and Medical Oncology and Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, OH, USA
    • ,
  • Eric D Hsi

      Affiliations

    • Department of Clinical Pathology, L11, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-216-444-5230; fax: +1-216-444-4414.

Received 12 September 2003; accepted 3 December 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(03)00418-1

doi:10.1016/j.leukres.2003.12.010

Leukemia Research
Volume 28, Issue 8 , Pages 845-850, August 2004

Article Tools

* Image Usage & Resolution